14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ZEPP vs SCKT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Zepp Health Corporation (ZEPP) captures the overall head-to-head institutional edge over Socket Mobile, Inc. New (SCKT) on higher Unified Composite conviction (45.7/100 HOLD vs. 50.9/100 HOLD) after splitting the core matrix 7–2 (led by Valuation Multiples, Profitability & Quality), while SCKT wins 3–2 across the 6-pillar growth and valuation breakdown. ZEPP trades at $2.31 (3.1x Forward P/E, -12.6% operating margin) versus SCKT at $0.26 (10.7x Forward P/E, -22.6% operating margin).
Composite vs. Pillar Nuance: While SCKT currently prints a higher short-term Unified Composite Score (50.9/100 HOLD vs. ZEPP 45.7/100 HOLD), ZEPP captures the overall institutional head-to-head verdict (7–2 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (-12.6% vs. -22.6% operating margin) and revenue trajectory (+6.9% vs. +9.1% YoY).
Technical & Structure Timing Caution: ZEPP is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.4); meanwhile SCKT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ZEPP vs SCKT. Trailing 12-month operating profitability (ZEPP -12.6% vs SCKT -22.6%) and valuation multiples (ZEPP 3.1x vs SCKT 10.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Computer Hardware value chain with $3.0M market capitalization and -22.6% operating margin.
OpEx & R&D Reinvestment71.9% of Rev ($10M)
90D Engineering Disclosures0 Published
Investor FAQ ZEPP vs SCKT Key Questions & Quantitative Answers
As of Nov 20, 2026, Zepp Health Corporation (ZEPP) captures the overall head-to-head institutional edge over Socket Mobile, Inc. New (SCKT) on higher Unified Composite conviction (45.7/100 HOLD vs. 50.9/100 HOLD) after splitting the core matrix 7–2 (led by Valuation Multiples, Profitability & Quality), while SCKT wins 3–2 across the 6-pillar growth and valuation breakdown. ZEPP trades at $2.31 (3.1x Forward P/E, -12.6% operating margin) versus SCKT at $0.26 (10.7x Forward P/E, -22.6% operating margin). Composite vs. Pillar Nuance: While SCKT currently prints a higher short-term Unified Composite Score (50.9/100 HOLD vs. ZEPP 45.7/100 HOLD), ZEPP captures the overall institutional head-to-head verdict (7–2 matrix metrics and 2–3 across the 6 pillars) due to superior fundamental profitability (-12.6% vs. -22.6% operating margin) and revenue trajectory (+6.9% vs. +9.1% YoY). Technical & Structure Timing Caution: ZEPP is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 35.4); meanwhile SCKT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 36.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SCKT leads the Growth & Scale pillar: ZEPP posts +6.9% YoY revenue growth and -68.1% YoY earnings growth on $276M TTM revenue (38.6% gross margin, -12.6% operating margin), compared with SCKT at +9.1% YoY revenue growth and -1.2% YoY earnings growth on $14M TTM revenue (49.3% gross margin, -22.6% operating margin). On trailing 12-month operating scale, ZEPP generates $276M in USD-normalized revenue versus $14M for SCKT. In operating R&D and SG&A reinvestment, ZEPP deploys 51.2% of Rev ($141M) (0 90-day corporate R&D disclosures) versus 71.9% of Rev ($10M) (0 disclosures) for SCKT.
ZEPP screens cheaper on headline valuation multiples. ZEPP trades at 3.1x Forward P/E, 3.1x Trailing P/E, N/M PEG, and 0.1x EV/Revenue (-11.0% EBITDA margin), whereas SCKT trades at 10.7x Forward P/E, 10.7x Trailing P/E, 4.49x PEG, and 0.7x EV/Revenue (-8.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ZEPP (-21.2% ROE) versus SCKT (-165.2% ROE) capital efficiency.
In options market volatility and institutional positioning, ZEPP carries 124.3% implied volatility (94th %ile, Extreme (>80th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.12β · 68% Vol realized risk). By comparison, SCKT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.40β · 343% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.